PPARA and glioblastoma: We have recently shown in glioblastoma stem cells and glioblastoma primary cells [7,28] that PPARα inhibition by specific antagonists (GW6471 and AA452) determined growth arrest, decreased expression of the enzymes of the mevalonate pathway, and reduced levels of cholesterol and cholesterol esters [7,28].